These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8485774)

  • 1. [The epidemic process in infections before and after active immunization. II. Changes in the number of susceptible individuals in the population during a natural epidemic and its control by active immunization].
    Mimra J; Farník J
    Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):7-11. PubMed ID: 8485774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The epidemic process in infections before and after active immunization. I. Comparison of long-term monitoring of the disease with a simple mathematical model].
    Mimra J; Farník J
    Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):3-6. PubMed ID: 8485770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas].
    Oliveira J; Dias N; Ferreira TM; da Cunha S; Costa D; Côrte-Real R; Meliço-Silvestre A
    Acta Med Port; 1999; 12(4-6):155-60. PubMed ID: 10481316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Overview of measles, mumps, rubella and varicella vaccination in adolescents and adults].
    Quast U; Arndt U
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S77-81. PubMed ID: 19353476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The present epidemiologic status and prognosis in measles].
    Sejda J; Prívorová A; Benes C
    Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 41(4):210-4. PubMed ID: 1394470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare workers and immunity to infectious diseases.
    Vagholkar S; Ng J; Chan RC; Bunker JM; Zwar NA
    Aust N Z J Public Health; 2008 Aug; 32(4):367-71. PubMed ID: 18782402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS; Han HW; Go U; Chung HW
    Vaccine; 2004 Dec; 23(3):290-7. PubMed ID: 15530670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
    Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mumps--still actual epidemiological problem in Poland].
    Pogorzelska M; Ołdak E; Sulik A
    Przegl Epidemiol; 2005; 59(4):841-9. PubMed ID: 16729425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
    An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaling properties of childhood infectious diseases epidemics before and after mass vaccination in Canada.
    Trottier H; Philippe P
    J Theor Biol; 2005 Aug; 235(3):326-37. PubMed ID: 15882695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Periodicity of chickenpox and epidemic parotitis].
    Grishanova GI; Khazova MIa
    Vopr Virusol; 1977; (5):612-7. PubMed ID: 145093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia.
    Wood JG; Gidding HF; Heywood A; Macartney K; McIntyre PB; Macintyre CR
    Vaccine; 2009 Jan; 27(2):313-8. PubMed ID: 18977272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI; Nakamura MA; Godoy MV; Kuri P; Lucas CA; Conyer RT
    J Infect Dis; 2004 May; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.